A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma.
Literature
Read More
Hyper-plexed biomarker imaging using the MultiOmyx™ platform enables novel systems biology insights for the diagnosis and treatment of disease
Literature
Read More
NeoGenomics Selected by Aurora Diagnostics as Primary Partner for Molecular, FISH, and Immunohistochemistry Testing
Press Release
Read More
NeoGenomics Reports Revenue of $18.2 Million and Adjusted EBITDA of $1.7 million for the First Quarter
Press Release
Read More
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
Press Release
Read More
Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers
Literature
Read More
NeoGenomics Reports Record Revenue of $18.3 Million, Adjusted EBITDA of $2.7 Million and Net Income of $0.02 per Share for the Fourth Quarter 2013
Press Release
Read More